Current evidence for avoidant restrictive food intake disorder: Implications for clinical practice and future directions.
ARFID
assessment
clinical practice
narrative review
prevalence
service delivery
treatment
Journal
JCPP advances
ISSN: 2692-9384
Titre abrégé: JCPP Adv
Pays: United States
ID NLM: 9918250414706676
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
21
12
2022
accepted:
06
03
2023
medline:
27
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
ARFID (avoidant restrictive food intake disorder) is a relatively new diagnostic term covering a number of well-recognised, clinically significant disturbances in eating behaviour unrelated to body weight/shape concerns. Its phenotypic heterogeneity combined with much about the condition remaining unknown, can contribute to uncertainties about best practice. While other reviews of the evidence base for ARFID exist, few specifically target health care professionals and implications for clinical practice. A narrative review was conducted to synthesise the findings of ARFID papers in scientific journals focussing on four key areas relevant to clinical practice: prevalence, assessment and characterisation of clinical presentations, treatment, and service delivery. Freely available online databases were searched for case studies and series, research reports, review articles, and meta-analyses. Findings were reviewed and practice implications considered, resulting in proposed clinical recommendations and future research directions. We discuss what is currently known about the four key areas included in this review. Based on available evidence as well as gaps identified in the literature, recommendations for clinical practice are derived and practice-related research priorities are proposed for each of the four of the areas explored. Prevalence studies highlight the need for referral and care pathways to be embedded across a range of health care services. While research into ARFID is increasing, further studies across all areas of ARFID are required and there remains a pressing need for guidance on systematic assessment, evidence-based management, and optimal service delivery models. Informed clinical practice is currently predominantly reliant on expert consensus and small-scale studies, with ongoing routine clinical data capture, robust treatment trials and evaluation of clinical pathways all required. Despite this, a number a positive practice points emerge.
Sections du résumé
Background
UNASSIGNED
ARFID (avoidant restrictive food intake disorder) is a relatively new diagnostic term covering a number of well-recognised, clinically significant disturbances in eating behaviour unrelated to body weight/shape concerns. Its phenotypic heterogeneity combined with much about the condition remaining unknown, can contribute to uncertainties about best practice. While other reviews of the evidence base for ARFID exist, few specifically target health care professionals and implications for clinical practice.
Methods
UNASSIGNED
A narrative review was conducted to synthesise the findings of ARFID papers in scientific journals focussing on four key areas relevant to clinical practice: prevalence, assessment and characterisation of clinical presentations, treatment, and service delivery. Freely available online databases were searched for case studies and series, research reports, review articles, and meta-analyses. Findings were reviewed and practice implications considered, resulting in proposed clinical recommendations and future research directions.
Results
UNASSIGNED
We discuss what is currently known about the four key areas included in this review. Based on available evidence as well as gaps identified in the literature, recommendations for clinical practice are derived and practice-related research priorities are proposed for each of the four of the areas explored.
Conclusion
UNASSIGNED
Prevalence studies highlight the need for referral and care pathways to be embedded across a range of health care services. While research into ARFID is increasing, further studies across all areas of ARFID are required and there remains a pressing need for guidance on systematic assessment, evidence-based management, and optimal service delivery models. Informed clinical practice is currently predominantly reliant on expert consensus and small-scale studies, with ongoing routine clinical data capture, robust treatment trials and evaluation of clinical pathways all required. Despite this, a number a positive practice points emerge.
Identifiants
pubmed: 37753149
doi: 10.1002/jcv2.12160
pii: JCV212160
pmc: PMC10519741
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12160Informations de copyright
© 2023 The Authors. JCPP Advances published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Eat Disord. 2018 Apr 27;6:7
pubmed: 29736239
Int J Eat Disord. 2021 Jun;54(6):981-985
pubmed: 33594728
J Pediatr. 2017 Feb;181:116-124.e4
pubmed: 27843007
Int J Eat Disord. 2018 Feb;51(2):170-173
pubmed: 29215749
J Adolesc Health. 2014 Jul;55(1):49-52
pubmed: 24506978
Transl Psychiatry. 2017 Jun 20;7(6):e1157
pubmed: 28632204
J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):658-63
pubmed: 26628445
Int J Eat Disord. 2019 Apr;52(4):378-387
pubmed: 30312485
Appetite. 2022 Jan 1;168:105735
pubmed: 34626753
Eat Weight Disord. 2019 Oct;24(5):959-962
pubmed: 30788778
Eur Eat Disord Rev. 2019 Jul;27(4):429-435
pubmed: 30868707
Curr Opin Psychiatry. 2021 Nov 1;34(6):532-542
pubmed: 34402460
Int J Eat Disord. 2020 Oct;53(10):1623-1635
pubmed: 33464594
Psychiatr Danub. 2018 Sep;30(3):370-373
pubmed: 30267531
Int J Eat Disord. 2019 Apr;52(4):410-418
pubmed: 30734346
J Eat Disord. 2017 Mar 1;5:7
pubmed: 28265411
J Adolesc Health. 2014 Dec;55(6):750-6
pubmed: 25200345
Int J Eat Disord. 2014 Jul;47(5):495-9
pubmed: 24343807
Int J Eat Disord. 2015 Jul;48(5):464-70
pubmed: 25142784
Int J Eat Disord. 2019 Apr;52(4):367-377
pubmed: 30636013
Int J Eat Disord. 2019 Apr;52(4):402-409
pubmed: 30632634
Psychiatry Res. 2020 Jun;288:112961
pubmed: 32283448
J Child Adolesc Psychopharmacol. 2014 Jun;24(5):296-7
pubmed: 24813692
J Eat Disord. 2018 Sep 26;6:22
pubmed: 30263118
Behav Res Ther. 2000 Aug;38(8):835-55
pubmed: 10937431
Int J Eat Disord. 2019 Apr;52(4):388-397
pubmed: 30843618
Int J Eat Disord. 2019 Apr;52(4):439-446
pubmed: 30578635
Int J Eat Disord. 2021 Jan;54(1):7-18
pubmed: 33314277
Front Psychiatry. 2021 Jul 16;12:680298
pubmed: 34349680
J Child Adolesc Psychopharmacol. 2017 Dec;27(10):920-922
pubmed: 29068721
J Adolesc Health. 2015 Jan;56(1):121-5
pubmed: 25530605
Int J Eat Disord. 2019 Apr;52(4):361-366
pubmed: 30758864
J Child Adolesc Psychopharmacol. 2018 Jul/Aug;28(6):425-426
pubmed: 29812956
Curr Probl Pediatr Adolesc Health Care. 2017 Apr;47(4):95-103
pubmed: 28532967
Eat Weight Disord. 2021 May;26(4):1279-1280
pubmed: 32926345
Eur Child Adolesc Psychiatry. 2008 Jun;17(4):209-16
pubmed: 17876499
J Am Coll Health. 2019 May-Jun;67(4):357-366
pubmed: 29979922
Eur Eat Disord Rev. 2021 Jan;29(1):60-73
pubmed: 33089950
Nutrients. 2021 Jan 27;13(2):
pubmed: 33513954
J Adolesc Health. 2015 Dec;57(6):673-8
pubmed: 26422290
Int J Eat Disord. 2016 Nov;49(11):1036-1039
pubmed: 27521251
Child Adolesc Psychiatr Clin N Am. 2019 Oct;28(4):557-565
pubmed: 31443874
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1282-1289.e1
pubmed: 34389486
Int J Eat Disord. 2019 Jun;52(6):721-729
pubmed: 30761560
Eur Child Adolesc Psychiatry. 2015 Jul;24(7):779-85
pubmed: 25296563
J Eat Disord. 2022 Oct 10;10(1):146
pubmed: 36217209
Curr Pediatr Rep. 2018 Jun;6(2):107-113
pubmed: 31134139
J Pediatr Gastroenterol Nutr. 2013 Nov;57(5):668-72
pubmed: 23783012
Behav Modif. 2009 Sep;33(5):520-36
pubmed: 19748900
Clin Gastroenterol Hepatol. 2020 Aug;18(9):1995-2002.e1
pubmed: 31669056
J Pediatr Adolesc Gynecol. 2020 Oct;33(5):466-469
pubmed: 32553711
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
J Eat Disord. 2018 Aug 03;6:20
pubmed: 30123505
J Eat Disord. 2014 Aug 02;2(1):21
pubmed: 25165558
Intern Med J. 2020 Jan;50(1):24-29
pubmed: 31943622
J Clin Child Adolesc Psychol. 2022 Sep-Oct;51(5):701-714
pubmed: 33769133
EClinicalMedicine. 2023 Aug 30;63:102190
pubmed: 37680940
Dev Med Child Neurol. 2022 Jun;64(6):691-700
pubmed: 35112345
J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):288-289
pubmed: 29588055
Dev Med Child Neurol. 2022 Feb;64(2):176-182
pubmed: 34405406
Front Psychiatry. 2021 Jun 09;12:668297
pubmed: 34177659
J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):743-9
pubmed: 24509305
J Adolesc Health. 2013 Aug;53(2):303-5
pubmed: 23684215
Int J Eat Disord. 2021 Mar;54(3):399-408
pubmed: 33283329
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Appetite. 2018 Aug 1;127:257-265
pubmed: 29738782
Curr Opin Pediatr. 2017 Aug;29(4):407-413
pubmed: 28537947
Appetite. 2007 Nov;49(3):708-11
pubmed: 17920728
J Eat Disord. 2017 Jul 3;5:21
pubmed: 28680630
Int J Eat Disord. 2019 Mar;52(3):230-238
pubmed: 30578644
J Autism Dev Disord. 2018 Oct;48(10):3344-3353
pubmed: 29744703
Appetite. 2019 Jun 1;137:62-72
pubmed: 30825493
Epidemiol Psychiatr Sci. 2019 Jan 30;29:e15
pubmed: 30696515
Br J Psychiatry. 1999 May;174:413-6
pubmed: 10616607
Neuropsychiatr Dis Treat. 2019 Nov 27;15:3313-3321
pubmed: 31819456
Int J Eat Disord. 2019 Apr;52(4):331-360
pubmed: 30489647
J Acad Nutr Diet. 2021 Mar;121(3):467-492
pubmed: 33221247
Eat Behav. 2015 Dec;19:106-9
pubmed: 26276708
J Acad Nutr Diet. 2018 Oct;118(10):1943-1950
pubmed: 30005820
J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):588-592
pubmed: 34908014
Int J Eat Disord. 2021 Apr;54(4):587-594
pubmed: 33300613
Neuropsychiatr Dis Treat. 2016 Jan 19;12:213-8
pubmed: 26855577
J Clin Child Adolesc Psychol. 2023 Mar-Apr;52(2):159-170
pubmed: 35950931
Appetite. 2018 Apr 1;123:32-42
pubmed: 29208483